Clinical Trials Logo

Clinical Trial Summary

This is a phase II clinical trial in which children with refractory infantile spasms (also called epileptic spasms or West syndrome) will be treated with fenfluramine, to evaluate efficacy, safety, and tolerability. Patients with infantile spasms that have not responded to treatment with vigabatrin and ACTH we will be invited to participate. Study participants will undergo baseline video-EEG, receive treatment with fenfluramine for 21 days, and then undergo repeat video-EEG to determine effectiveness. Patients with favorable response will have the opportunity to continue treatment for up to 6 months.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT04289467
Study type Interventional
Source Children's Hospital of Orange County
Contact Angelyque Lorenzana, MA
Phone 714-509-8972
Email alorenzana@choc.org
Status Recruiting
Phase Phase 2
Start date June 16, 2023
Completion date December 31, 2025

See also
  Status Clinical Trial Phase
Terminated NCT03421496 - A Study to Assess Cannabidiol Oral Solution With Vigabatrin as Initial Therapy in Participants With Infantile Spasms Phase 3
Active, not recruiting NCT04727970 - Tricaprilin Infantile Spasms Pilot Study Phase 1
Recruiting NCT04302116 - Vigabatrin With High Dose Prednisolone Combination Therapy vs Vigabatrin Alone for Infantile Spasm N/A
Active, not recruiting NCT05279118 - Ketogenic Diet vs ACTH for the Treatment of Children With West Syndrome Phase 2/Phase 3
Recruiting NCT06266234 - Characterization by Automated System on Infantile Spasmes
Completed NCT05538936 - The Effect of Spa and Massage on Babies on Colic Symptoms N/A
Suspended NCT03347526 - A Novel Approach to Infantile Spasms Phase 3
Recruiting NCT03876444 - Intravenous Methylprednisolone Versus Oral Prednisolone for Infantile Spasms Phase 2/Phase 3